ADC Therapeutics SA at RBC Capital Markets Global Healthcare Conference Transcript
Welcome back, everyone, to the 2023 RBC Global Healthcare Conference. My name is Greg Renza, one of the senior biotech equity research analysts here at RBC. And we're pleased to have ADC Therapeutics. Joining us from the company is the Chief Executive Officer, Ameet Mallik. Ameet, it's a pleasure to see you, and thanks for being here.
Well, thank you for having me. It's a pleasure to be here.
Questions & Answers
Great. Well, maybe we can just get started by just having you give an introduction to ADC, maybe for those who aren't familiar with the company, with the pipeline and ZYNLONTA, and the technology?
Sure. Well, thank you. Just as you're aware, ADC Therapeutics is a pioneer and is a leader in the space of antibody drug conjugates. We're a fully integrated company. We have one approved product on
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
